This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fantin, B.
Right arrow Articles by Carbon, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fantin, B.
Right arrow Articles by Carbon, C.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, 05 1997, 931-935, Vol 41, No. 5
Copyright © 1997 by the American Society for Microbiology. All rights reserved.

Influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B-type antibiotics in Enterococcus faecium on activity of quinupristin-dalfopristin in vitro and in rabbits with experimental endocarditis

B Fantin, R Leclercq, L Garry and C Carbon
Institut National de la Sante et de la Recherche Medicale, Unite 13,and Universite Paris VII, Paris, France.

The influence of inducible cross-resistance to macrolides, lincosamides, and streptogramin B (MLS(B)) type antibiotics (inducible MLS(B) phenotype) on the activity of quinupristin-dalfopristin was investigated against Enterococcus faecium in vitro and in rabbits with experimental endocarditis. In vitro, quinupristin-dalfopristin displayed bacteriostatic and bactericidal activities against a MLS(B)- susceptible strain similar to those against two strains with the inducible MLS(B) phenotype. In addition, induction of the two MLS(B)- resistant strains with quinupristin (0.016 to 1 microg/ml) or quinupristin-dalfopristin (0.08 to 0.25 microg/ml) increased the MICs of quinupristin from 8 microg/ml to 32 to > 128 microg/ml, but did not modify the MIC of dalfopristin (2 microg/ml) or quinupristin- dalfopristin (0.5 microg/ml). In a rabbit endocarditis model, quinupristin-dalfopristin was as active as amoxicillin against the MLS(B)-susceptible E. faecium strain. In contrast, the activity of quinupristin-dalfopristin was significantly decreased in animals infected with either of the two inducible MLS(B)-resistant strains (P < 0.05), although no mutants resistant to quinupristin-dalfopristin were detected. Against the clinical strain with the inducible MLS(B) phenotype, quinupristin-dalfopristin was not effective and was less active than amoxicillin (P < 0.001); however, the activity of the combination of amoxicillin and dalfopristin-quinupristin was superior to that of amoxicillin (P < 0.01). The different impact of the inducible MLS(B) phenotype in E. faecium on the activity of quinupristin-dalfopristin in vitro and in experimental endocarditis may be related to the reduced diffusion of dalfopristin compared with that of quinupristin into cardiac vegetations that we previously reported. This result emphasizes the importance of the constant presence of dalfopristin at the site of infection to ensure synergism with quinupristin.


This article has been cited by other articles:

  • Lefort, A., Garry, L., Depardieu, F., Courvalin, P., Fantin, B. (2003). Influence of VanD Type Resistance on Activities of Glycopeptides In Vitro and in Experimental Endocarditis Due to Enterococcus faecium. Antimicrob. Agents Chemother. 47: 3515-3518 [Abstract] [Full Text]  
  • Eliopoulos, G. M., Wennersten, C. B. (2002). Antimicrobial Activity of Quinupristin-Dalfopristin Combined with Other Antibiotics against Vancomycin-Resistant Enterococci. Antimicrob. Agents Chemother. 46: 1319-1324 [Abstract] [Full Text]  
  • Singh, K. V., Zscheck, K. K., Murray, B. E. (2000). Efficacy of Telithromycin (HMR 3647) against Enterococci in a Mouse Peritonitis Model. Antimicrob. Agents Chemother. 44: 3434-3437 [Abstract] [Full Text]  
  • Vouillamoz, J., Entenza, J. M., Féger, C., Glauser, M. P., Moreillon, P. (2000). Quinupristin-Dalfopristin Combined with beta -Lactams for Treatment of Experimental Endocarditis Due to Staphylococcus aureus Constitutively Resistant to Macrolide-Lincosamide-Streptogramin B Antibiotics. Antimicrob. Agents Chemother. 44: 1789-1795 [Abstract] [Full Text]  
  • Murray, B. E. (2000). Vancomycin-Resistant Enterococcal Infections. NEJM 342: 710-721 [Full Text]  
  • Bozdogan, B., Leclercq, R. (1999). Effects of Genes Encoding Resistance to Streptogramins A and B on the Activity of Quinupristin-Dalfopristin against Enterococcus faecium. Antimicrob. Agents Chemother. 43: 2720-2725 [Abstract] [Full Text]  
  • Schlegel, L., Sissia, G., Fremaux, A., Geslin, P. (1999). Diminished Killing of Pneumococci by Pristinamycin Demonstrated by Time-Kill Studies. Antimicrob. Agents Chemother. 43: 2099-2100 [Full Text]  
  • Schmitz, F.-J., Verhoef, J., Fluit, A. C., The Sentry Participants Group, (1999). Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme. J Antimicrob Chemother 43: 783-792 [Abstract] [Full Text]  
  • Saleh-Mghir, A., Lefort, A., Petegnief, Y., Dautrey, S., Vallois, J.-M., Le Guludec, D., Carbon, C., Fantin, B. (1999). Activity and Diffusion of LY333328 in Experimental Endocarditis Due to Vancomycin-Resistant Enterococcus faecalis. Antimicrob. Agents Chemother. 43: 115-120 [Abstract] [Full Text]  
  • Aeschlimann, J. R., Zervos, M. J., Rybak, M. J. (1998). Treatment of Vancomycin-Resistant Enterococcus faecium with RP 59500 (Quinupristin-Dalfopristin) Administered by Intermittent or Continuous Infusion, Alone or in Combination with Doxycycline, in an In Vitro Pharmacodynamic Infection Model with Simulated Endocardial Vegetations. Antimicrob. Agents Chemother. 42: 2710-2717 [Abstract] [Full Text]  
  • Aeschlimann, J. R., Rybak, M. J. (1998). Pharmacodynamic Analysis of the Activity of Quinupristin-Dalfopristin against Vancomycin-Resistant Enterococcus faecium with Differing MBCs via Time-Kill-Curve and Postantibiotic Effect Methods. Antimicrob. Agents Chemother. 42: 2188-2192 [Abstract] [Full Text]  
  • Wang, G., Taylor, D. E. (1998). Site-Specific Mutations in the 23S rRNA Gene of Helicobacter pylori Confer Two Types of Resistance to Macrolide-Lincosamide-Streptogramin B Antibiotics. Antimicrob. Agents Chemother. 42: 1952-1958 [Abstract] [Full Text]  
  • Rosato, A., Vicarini, H., Bonnefoy, A., Chantot, J.-F., Leclercq, R. (1998). A New Ketolide, HMR 3004, Active against Streptococci Inducibly Resistant to Erythromycin. Antimicrob. Agents Chemother. 42: 1392-1396 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»